Urgent recall: Blood Pressure Medication Prazosin – What You Need to Know Now
(Last Updated: october 31, 2025)
A significant nationwide recall has been issued by the FDA for over 580,000 bottles of Prazosin Hydrochloride, a commonly prescribed blood pressure medication. This recall stems from the detection of a potentially cancer-causing chemical impurity. As a healthcare advocate, I understand this news can be concerning, so letS break down exactly what’s happening, which medications are affected, and – most importantly – what you should do to protect your health.
What’s the Issue? Understanding Nitrosamine Impurities
The FDA has identified unacceptable levels of N-nitroso prazosin impurity C, a type of nitrosamine, in certain batches of Prazosin Hydrochloride. Nitrosamines are known to potentially increase cancer risk over long-term exposure. While the risk to individuals is considered remote in this specific case (classified as a Class II recall), it’s crucial to be informed and take the recommended steps.
This impurity can arise during the manufacturing or storage of the medication, and pharmaceutical companies are working diligently to understand and prevent its formation.
Which Prazosin Medications Are Affected?
The recall specifically impacts Prazosin Hydrochloride capsules manufactured by Teva Pharmaceuticals and distributed by Amerisource Health Services. Here’s a breakdown:
* Drug Name: Prazosin Hydrochloride
* Strengths: 1 mg, 2 mg, and 5 mg capsules
* Lot Numbers: Crucially, you need to check your specific lot number. The FDA’s official recall notice (linked below) contains a complete list.
* Expiration Dates: April 2026 – September 2027
* Uses: Primarily used to treat high blood pressure (hypertension) and symptoms related to Post-Traumatic Stress Disorder (PTSD).
find the complete recall details and affected lot numbers here: https://www.accessdata.fda.gov/scripts/ires/?Product=216512
What Should You Do? A Step-by-Step Guide
Do NOT stop taking your medication without consulting your doctor. Abruptly stopping blood pressure medication can be hazardous and lead to serious health complications. Here’s what to do right now:
- Locate Your Medication: Find your bottle of Prazosin Hydrochloride.
- Check the Lot Number: Compare the lot number on your bottle to the list provided on the FDA’s recall notice (link above).
- Contact Your Healthcare Provider: If your lot number is on the recall list, immediately contact your doctor or pharmacist.They will advise you on the best course of action, which may include a prescription for a different medication.
- Report Adverse Events: If you experience any unexpected side effects, report them to the FDA’s MedWatch program: https://www.fda.gov/safety/medwatch
Understanding the FDA Recall Classifications
The FDA classifies recalls based on the severity of the health risk. This recall is a Class II recall, meaning:
* remote Risk of Serious Harm: The FDA believes the risk of serious adverse health effects is low.
* Potential for Temporary Effects: There’s a possibility of temporary or medically reversible health consequences.
* Proactive Measure: The recall is a proactive step to ensure patient safety and maintain the quality of medications.
What is Teva Pharmaceuticals Saying?
Teva Pharmaceuticals has acknowledged the recall and emphasized their commitment to patient safety. They state that choice treatments for hypertension are readily available. They’ve also reinforced their dedication to rigorous quality control throughout the entire medication lifecycle.
Looking Ahead: preventing Future Contamination
The FDA is actively working with manufacturers to identify the root causes of nitrosamine contamination and implement preventative measures. This includes enhanced testing protocols and improvements to manufacturing processes. This recall serves as a critical reminder of the importance of ongoing vigilance in pharmaceutical quality control.
Your health is paramount. Don’t hesitate to reach out to your healthcare provider with any questions or concerns. Staying informed and
Keep reading